Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 85,826
  • Shares Outstanding, K 191,791
  • Annual Sales, $ 46,740 K
  • Annual Income, $ -114,330 K
  • EBIT $ -88 M
  • EBITDA $ -84 M
  • 60-Month Beta 0.96
  • Price/Sales 1.81
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings $-0.18 on 08/13/24
  • Next Earnings Date 12/24/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 175.24% ( +19.07%)
  • Historical Volatility 110.19%
  • IV Percentile 72%
  • IV Rank 25.51%
  • IV High 640.19% on 10/10/24
  • IV Low 16.01% on 03/13/24
  • Put/Call Vol Ratio 4.59
  • Today's Volume 419
  • Volume Avg (30-Day) 467
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 26,654
  • Open Int (30-Day) 23,131

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.20
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.30
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +68.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4300 +4.07%
on 12/20/24
0.7450 -39.93%
on 12/02/24
-0.1171 (-20.74%)
since 11/20/24
3-Month
0.4300 +4.07%
on 12/20/24
1.1400 -60.75%
on 11/06/24
-0.5525 (-55.25%)
since 09/20/24
52-Week
0.4300 +4.07%
on 12/20/24
2.6300 -82.98%
on 02/29/24
-0.8525 (-65.58%)
since 12/20/23

Most Recent Stories

More News
Scilex Holding Company Announces Early Repayment of $13.2 Million Under Oramed Note

Scilex Holding Company announces a $13.2 million early payment on its Oramed Note, reducing remaining balance due March 2025.Quiver AI SummaryScilex Holding Company, based in Palo Alto, California, has...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Closes Registered Direct Offering, Raising Approximately $17 Million

Scilex Holding Company closed a direct stock offering, raising approximately $17 million for corporate purposes and product development.Quiver AI SummaryScilex Holding Company has successfully closed a...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Agreement for Sale of Common Stock and Warrants, Expected Gross Proceeds of $17 Million

Scilex Holding Company announces a $17 million stock offering for growth and development in pain management therapies.Quiver AI SummaryScilex Holding Company announced a definitive agreement with institutional...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces $17 Million Registered Direct Offering

SCLX : 0.4475 (+1.64%)
Scilex Bio Announces Ongoing Phase 2 Trial for KDS2010 in Obesity Treatment, Expanding to U.S. in 2025

KDS2010 Phase 2 trial evaluates safety and efficacy for obesity treatment; positive Phase 1 results reported.Quiver AI SummaryScilex Bio has announced an ongoing Phase 2 clinical trial for KDS2010, a novel...

SCLX : 0.4475 (+1.64%)
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025

SCLX : 0.4475 (+1.64%)
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed...

SCLX : 0.4475 (+1.64%)
NeuroBiogen Company and Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company enter into Binding Term Sheet for Worldwide License, Along with the Rights to Sublicense for All of KDS2010 indications; Binding Term Sheet...

SCLX : 0.4475 (+1.64%)

Business Summary

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

See More

Key Turning Points

3rd Resistance Point 0.4750
2nd Resistance Point 0.4625
1st Resistance Point 0.4550
Last Price 0.4475
1st Support Level 0.4350
2nd Support Level 0.4225
3rd Support Level 0.4150

See More

52-Week High 2.6300
Fibonacci 61.8% 1.7896
Fibonacci 50% 1.5300
Fibonacci 38.2% 1.2704
Last Price 0.4475
52-Week Low 0.4300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar